Table 5

Treatment response in 40 patients with CCPD

TreatmentEfficacy n/N (%)
Corticosteroid pulse therapy*30/36 (83.3)
Oral corticosteroids21/28 (75.0)
IVIg18/27 (66.7)
Plasmapheresis7/8 (87.5)
IFN-β1/10 (10.0)
  • *500 mg/day for three consecutive days were administered to two patients, while 1000 mg/day for three consecutive days were administered to the remaining patients.

  • CCPD, combined central and peripheral demyelination; IFN-β, interferon β; IVIg, intravenous immunoglobulin; N, number of cases collated; n, number of efficacious cases.